How the RMRP Gene Causes CHH Symptoms
Last updated:
Cartilage-Hair Hypoplasia (CHH) is caused by a mutation in the RMRP gene, which disrupts the body's ribosomes or protein factories. This defect slows down cell division, particularly affecting fast-growing tissues, which leads to short stature, sparse hair, and weakened immune function.
Key Takeaways
- • Cartilage-Hair Hypoplasia is a ribosomopathy caused by mutations in the RMRP gene.
- • The gene mutation impairs cellular protein factories, causing cells to stall during division and growth.
- • Cartilage cells fail to mature properly, resulting in disproportionate short stature and metaphyseal dysplasia.
- • Fast-dividing cells are heavily impacted, causing extra-skeletal symptoms like sparse hair, immune deficiency, and macrocytic anemia.
- • The MDWH variant primarily causes skeletal issues without initial hair or immune problems, but symptoms can change over time.
Cartilage-Hair Hypoplasia (CHH) is a complex condition because a single genetic “glitch” in the RMRP gene acts like a master switch, affecting multiple systems in the body [1]. To understand why one gene causes everything from short stature to immune issues, it helps to look at the role of the ribosome—the body’s “protein factory” [2].
The Root Cause: A “Ribosomopathy”
CHH is scientifically classified as a ribosomopathy [2]. Every cell in your child’s body needs ribosomes to build the proteins required for life and growth [2]. The RMRP gene provides the instructions for a specific piece of machinery (a non-coding RNA) that helps assemble these protein factories [3].
When the RMRP gene is mutated:
- Protein Factories Fail: The cell cannot produce enough healthy ribosomes, or the ones it does produce don’t work correctly [2].
- Cell Cycle Stalling: Because the protein “supply chain” is broken, cells struggle to divide and grow. They often get “stuck” in a specific phase of the cell cycle (the G2 to M phase), which slows down the production of new tissue [4].
Why Bones and the Immune System?
While the ribosome defect exists in almost all cells, it hits two types of cells particularly hard: chondrocytes (bone-building cells) and lymphocytes (immune-fighting cells) [5][6].
Skeletal Symptoms (The “Cartilage” and “Short Stature”)
The bones in our arms and legs grow through a process where cartilage cells “super-size” themselves (hypertrophy) and then turn into bone [5]. In CHH, the ribosome defect prevents these cartilage cells from maturing properly [7]. This leads to:
- Disproportionate Short Stature: Short limbs relative to the torso [1].
- Metaphyseal Dysplasia: Abnormalities at the ends of the long bones, which can be seen on X-rays [8].
- Difference from Achondroplasia: While both cause short stature, CHH is unique because it also involves fine hair and potential immune issues, which are not seen in achondroplasia [9].
Extra-Skeletal Symptoms (The “Hair” and Beyond)
The ribosome defect also impacts fast-dividing cells and specific organ systems:
- Hypotrichosis (Sparse Hair): The cells in hair follicles are some of the fastest-dividing in the body; when the “factories” fail, hair grows in fine, sparse, and light-colored [1].
- Immune Deficiency: Lymphocytes (T-cells) struggle to multiply to fight off infections [2]. This can also be linked to shorter telomeres (the protective caps on the ends of DNA), which cause immune cells to age or die prematurely [6].
- Macrocytic Anemia: Red blood cells may be larger than normal but fewer in number because the bone marrow cannot produce them efficiently [10].
- Hirschsprung Disease: Some children are born without certain nerve cells in the wall of the colon, leading to severe constipation or intestinal blockage [11].
Spectrum and Variants
Because every child’s genetic “recipe” is slightly different, the symptoms vary widely.
- MDWH (Metaphyseal Dysplasia without Hypotrichosis): This is a milder variant where a child has the bone growth features of CHH but appears to have normal hair and a healthier immune system, at least initially [8].
- Changing Phenotypes: It is important to know that some children who start with “only” skeletal issues (like MDWH) can develop immune or blood issues later in life, so long-term monitoring is essential [12].
Frequently Asked Questions
What does it mean that CHH is a ribosomopathy?
Why does the RMRP gene mutation cause short stature?
Why does Cartilage-Hair Hypoplasia cause sparse hair?
Can CHH affect my child's digestive system?
What is the difference between CHH and MDWH?
Questions for Your Doctor
- • My child’s condition is called a 'ribosomopathy'—can you explain what that means for their daily care and monitoring?
- • Is my child’s skeletal dysplasia progressing as expected, or are there specific orthopedic interventions we should consider?
- • Given that Hirschsprung disease can be part of this condition, what specific digestive red flags should I watch for in an infant?
- • How frequently should we be testing for macrocytic anemia and immune cell counts?
- • How does my child’s specific RMRP mutation correlate with their risk for the more severe 'extra-skeletal' symptoms?
Questions for You
- • Have I noticed any unusual patterns in my child's hair growth or texture compared to their siblings or peers?
- • How has my child’s growth (height and weight) tracked on standard growth charts since birth?
- • Have we noticed any signs of persistent constipation or digestive discomfort that might suggest a gastrointestinal issue?
- • Is there a family history of autoimmune issues, severe infections, or childhood cancers?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Neonatal erythroderma and immunodysplasia: Overlap of cartilage-hair hypoplasia and Omenn syndrome.
Insalaco A, Rossi C, Bertucci E, et al.
European journal of medical genetics 2026; (80()):105069 doi:10.1016/j.ejmg.2026.105069.
PMID: 41616907 - 2
A disease-linked lncRNA mutation in RNase MRP inhibits ribosome synthesis.
Robertson N, Shchepachev V, Wright D, et al.
Nature communications 2022; (13(1)):649 doi:10.1038/s41467-022-28295-8.
PMID: 35115551 - 3
A novel experimental approach for the selective isolation and characterization of human RNase MRP.
Derksen M, Mertens V, Visser EA, et al.
RNA biology 2022; (19(1)):305-312 doi:10.1080/15476286.2022.2027659.
PMID: 35129080 - 4
The human long non-coding RNA gene RMRP has pleiotropic effects and regulates cell-cycle progression at G2.
Vakkilainen S, Skoog T, Einarsdottir E, et al.
Scientific reports 2019; (9(1)):13758 doi:10.1038/s41598-019-50334-6.
PMID: 31551465 - 5
Expression of RMRP RNA is regulated in chondrocyte hypertrophy and determines chondrogenic differentiation.
Steinbusch MMF, Caron MMJ, Surtel DAM, et al.
Scientific reports 2017; (7(1)):6440 doi:10.1038/s41598-017-06809-5.
PMID: 28743979 - 6
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia.
Aubert G, Strauss KA, Lansdorp PM, Rider NL
The Journal of allergy and clinical immunology 2017; (140(4)):1120-1129.e1 doi:10.1016/j.jaci.2016.11.051.
PMID: 28126377 - 7
Uncovering pathways regulating chondrogenic differentiation of CHH fibroblasts.
Chabronova A, van den Akker GGH, Meekels-Steinbusch MMF, et al.
Non-coding RNA research 2021; (6(4)):211-224 doi:10.1016/j.ncrna.2021.12.003.
PMID: 34988338 - 8
Cartilage-hair hypoplasia-anauxetic dysplasia spectrum disorders harboring RMRP mutations in two Korean children: A case report.
Park JH, Im M, Kim YJ, et al.
Medicine 2024; (103(21)):e37247 doi:10.1097/MD.0000000000037247.
PMID: 38787970 - 9
RMRP variants inhibit the cell cycle checkpoints pathway in cartilage‑hair hypoplasia.
Gao J, Zheng J, Chen S, et al.
Molecular medicine reports 2025; (31(3)).
PMID: 39886981 - 10
Anemia in patients with cartilage hair hypoplasia: a narrative review and recommendations.
Lewandowska N, Ordak M
Laboratory medicine 2025; (56(3)):213-219 doi:10.1093/labmed/lmae082.
PMID: 39321258 - 11
Immunologic Heterogeneity in 2 Cartilage-Hair Hypoplasia Patients With a Distinct Clinical Course.
Gamliel A, Lee YN, Lev A, et al.
Journal of investigational allergology & clinical immunology 2023; (33(4)):263-270 doi:10.18176/jiaci.0792.
PMID: 35166674 - 12
'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.
Vakkilainen S, Costantini A, Taskinen M, et al.
Journal of medical genetics 2020; (57(1)):18-22 doi:10.1136/jmedgenet-2019-106131.
PMID: 31413121
This page provides educational information about the genetic causes of Cartilage-Hair Hypoplasia. It is not a substitute for professional medical advice from a pediatric geneticist or specialist.
Stay up to date
Get notified when new research about Cartilage-hair hypoplasia is published.
No spam. Unsubscribe anytime.